Worldquant Millennium Advisors LLC Novavax Inc Transaction History

Worldquant Millennium Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $3.91 Million - $8.12 Million	107,853 Added 309.11%	142,745 $7.34 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $2.43 Million - $4.99 Million	34,892 New	34,892 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $15.1 Million - $24.4 Million	-112,069 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $11.5 Million - $17.5 Million	64,501 Added 135.6%	112,069 $23.2 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $5.76 Million - $12.3 Million	47,568 New	47,568 $10.1 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.